To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Westminster Hall
PANS and PANDAS - Tue 12 Sep 2023
Department for Business and Trade

Mentions:
1: Selaine Saxby (CON - North Devon) That is what makes PANS and PANDAS so shocking. - Speech Link
2: Robin Millar (CON - Aberconwy) of the APPG on PANS and PANDAS, I also extend my gratitude to the organisation PANS PANDAS UK. - Speech Link
3: Jim Shannon (DUP - Strangford) Lady to highlight the issue of PANS and PANDAS. - Speech Link
4: Andrew Selous (CON - South West Bedfordshire) of children with PANS and PANDAS—we must remember them. - Speech Link


Parliamentary Research
Debate on Pediatric Acute-onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections - CDP-2023-0174
Aug. 23 2023

Found: Debate on Pediatric Acute-onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders


Written Question
Paediatric Acute-onset Neuropsychiatric Syndrome: Children and Young People
Tuesday 12th September 2023

Asked by: Jonathan Ashworth (Labour (Co-op) - Leicester South)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that children and young people living with PANS and PANDAS receive effective, patient-centred care.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS)

are an emerging area of research and clinical interest for professionals working with children and young people. Should the evidence base develop further, we would look to organisations such as the National Institute for Health and Care Excellence to update clinical policy. NHS England would then consider the development of care pathways for those living with relevant these conditions.

In the meantime, integrated care systems are responsible for planning care for their populations affected by these conditions and healthcare professionals will want to take account of any new research and developments in guidance to ensure that they can continue to provide high quality care to their patients.


Written Question
Paediatric Acute-onset Neuropsychiatric Syndrome: Health Services
Thursday 19th October 2023

Asked by: Jonathan Ashworth (Labour (Co-op) - Leicester South)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost of providing care to those with (a) PANS and (b) PANDAS who have (i) been hospitalised and (ii) left with enduring and life-changing symptoms after receiving in-effective healthcare treatment.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Department has made no such estimate as the number of patients affected in this way is currently unknown.


Written Question
Paediatric Acute-onset Neuropsychiatric Syndrome
Thursday 14th September 2023

Asked by: Jonathan Ashworth (Labour (Co-op) - Leicester South)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of recognising PANS and PANDAS as a condition eligible for personalised NHS treatment.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

No assessment has been made.


Written Question
Diseases: Children and Young People
Monday 11th September 2023

Asked by: Jonathan Ashworth (Labour (Co-op) - Leicester South)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent discussions he has had with (a) Cabinet colleagues and (b) stakeholders on the development of care pathways for children and young people living with (i) Paediatric Acute-onset Neuropsychiatric Syndrome (PANS), (ii) Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) and (iii) associated immune mediated/post-infective neuro-behavioural disorders.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

No such discussions have taken place recently.


Select Committee
2023-06-27 16:15:00+01:00

Oral Evidence Jun. 27 2023

Inquiry: Proposals for backbench debates
Inquiry Status: Open
Committee: Backbench Business Committee

Found: Yes, PANS/PANDAS is how the conditions are commonly known, and no, they have nothing to do with the


Select Committee
Session 2022-23 List of Subjects Debated

Minutes and decisions Dec. 01 2023

Committee: Backbench Business Committee

Found: Session 2022-23 List of Subjects Debated Minutes and decisions


Written Question
Paediatric Acute-onset Neuropsychiatric Syndrome: Children
Friday 24th March 2023

Asked by: Luke Evans (Conservative - Bosworth)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he (a) has had and (b) plans to have discussions with NHS England on ensuring the (i) adequacy and (ii) consistency of treatment pathways for children living with (A) PANS and (B) PANDAS; and what steps he is taking to ensure that children living with (1) PANS and (2) PANDAS and their parents receive adequate (x) information and (y) support to take informed decisions on care pathway options.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

No such discussions with NHS England have taken place or are planned at present. Should the evidence base develop further, clinical policy may be updated by relevant organisations such as the National Institute for Health and Care Excellence. NHS England would then consider the development of care pathways for those living with PANS and PANDAS. In the meantime, integrated care systems are responsible for planning care for their populations.


Early Day Motion
PANS PANDAS UK Working Group Statement, 24 February 2023 (6 Signatures)
8 Mar 2023
Tabled by: Wendy Chamberlain (Liberal Democrat - North East Fife)
That this House notes the statement dated 24 February 2023 from the PANS PANDAS Working Group aiming at improving standards of care for patients with symptoms of Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS); recognises that the working group included representatives of …